Arrowhead Pharmaceuticals, Inc. · NASDAQ:ARWR
Vanguard Portfolio Management LLC's stake in Arrowhead Pharmaceuticals, Inc. fell to 4.53% (Schedule 13G/A)
Event Jun 30, 2026 · Filed Jul 31, 2026
Vanguard Portfolio Management LLC's stake in Arrowhead Pharmaceuticals, Inc. fell to 4.53%, 6,384,903 shares, as a passive investor on Jun 30, 2026. Filed Jul 31, 2026 (Schedule 13G/A).
- Stake
- 4.53%
- Shares
- 6,384,903
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vanguard Portfolio Management | 4.53% | 6,384,903 |
Source
Related
- Arrowhead Pharmaceuticals, Inc.
- Vanguard Portfolio Management LLC
- Arrowhead Pharmaceuticals, Inc. shareholders
- Schedule 13G · Vanguard Portfolio Management LLC · Apr 28, 2026
- Form 4 · Olukotun Adeoye Y · Aug 20, 2026
- Form 4 · Perry Michael S · Aug 20, 2026
- Schedule 13G/A · Avoro Capital Advisors LLC · Aug 14, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 27, 2026
- Form 4 · Cohen Matthew Gregory · Jun 17, 2026